1 Mahadevan D, List AF.Targeting the multidrug resistance-1 transporter in AML:molecular regulation and therapeutic strategies[J].Blood, 2004;104:1940-51 2 陆彬.药物新剂型与新技术[M].北京:人民卫生出版社, 1998:108 3 张晓云, 倪京满, 乔华.RP-HPLC 法测定鬼臼毒素纳米脂质体的包封率[J].中药材, 2005;28:954-5 4 俞建, 陈彻, 高培龙, 贾正平.鬼臼酰肼对白血病K562 细胞株作用的实验研究[J].中药材, 2005;28:111-3 5 Wilkins RC, Kutzner BC, Truong M, Sanchez-Dardon J,McLeanb JRN.Analysis of radiation-induced apoptosis in human lymphocytes:flow cytometry using Annexin V and propidium iodide versus the neutral comet assay [J].Cytometry,2002;48:14-9 6 GordalizaM, Castro MA, Del Corral JMM, Feliciano AS.Antitumor properties of podophyllotoxin and related compounds [J].Curr Pharm Des, 2000;6:1811-39 7 金伟, 李亚莉, 姜民, 王亚威, 顾少华, 季朝能, 等.鬼臼毒素对人K562 白血病细胞的作用研究[J].中医药信息,2001;18:48-51 8 曾抗, 张三泉, 江彬彬, 孙乐栋, 李建华, 马晓冬, 等.脂质体鬼臼毒素混悬液在大鼠表皮及真皮的分布规律初探[J].中华皮肤科杂志, 2003;36:329-31 9 Wang ZJ, He YY, Huang CG, Huang JS, Huang YC, An JY,et al.Pharmacokinetics tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy[J].Photochem Photobiol,1999;70:773-80 10 张晓云, 倪京满, 乔华.鬼臼毒素纳米脂质体抗肿瘤作用的研究[J].中国中药杂志, 2006;31:148-50 |